KYC is one time exercise with a SEBI registered intermediary while dealing in securities markets (Broker/ DP/ Mutual Fund etc.). | No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account.   |   Prevent unauthorized transactions in your account – Update your mobile numbers / email ids with your stock brokers. Receive information of your transactions directly from exchange on your mobile / email at the EOD | Filing Complaint on SCORES - QUICK & EASY a) Register on SCORES b) Mandatory details for filing complaints on SCORE - Name, PAN, Email, Address and Mob. no. c) Benefits - speedy redressal & Effective communication   |   BSE Prices delayed by 5 minutes...<< Prices as on Jun 23, 2026 - 11:27AM >>  ABB India 7221  [ -0.47% ]  ACC 1349  [ 0.01% ]  Ambuja Cements 425.45  [ -0.56% ]  Asian Paints 2682.8  [ 0.31% ]  Axis Bank 1365  [ 0.46% ]  Bajaj Auto 10204  [ 0.06% ]  Bank of Baroda 282.8  [ -1.15% ]  Bharti Airtel 1917.45  [ 0.03% ]  Bharat Heavy 409.55  [ -0.51% ]  Bharat Petroleum 310.75  [ 0.73% ]  Britannia Industries 5252  [ 0.71% ]  Cipla 1449.4  [ 2.41% ]  Coal India 447.9  [ -0.22% ]  Colgate Palm 1995.1  [ 0.67% ]  Dabur India 422.65  [ 0.07% ]  DLF 634.8  [ 1.22% ]  Dr. Reddy's Lab. 1313.75  [ 1.76% ]  GAIL (India) 174.35  [ -1.66% ]  Grasim Industries 3165.6  [ -0.33% ]  HCL Technologies 1115.3  [ -1.31% ]  HDFC Bank 790.5  [ 0.55% ]  Hero MotoCorp 4973.5  [ -0.23% ]  Hindustan Unilever 2168.2  [ -0.77% ]  Hindalco Industries 987.5  [ -2.66% ]  ICICI Bank 1363.25  [ 0.86% ]  Indian Hotels Co. 725.4  [ -1.00% ]  IndusInd Bank 917  [ -0.65% ]  Infosys 1035.4  [ -2.82% ]  ITC 292  [ 0.27% ]  Jindal Steel 1117.55  [ -1.27% ]  Kotak Mahindra Bank 403.7  [ 0.37% ]  L&T 4229.8  [ 0.70% ]  Lupin 2370.55  [ 1.33% ]  Mahi. & Mahi 3064.95  [ -0.14% ]  Maruti Suzuki India 13350  [ -0.47% ]  MTNL 31.6  [ -1.25% ]  Nestle India 1406.2  [ 0.31% ]  NIIT 102.2  [ -1.53% ]  NMDC 86.75  [ -1.63% ]  NTPC 365.7  [ -0.34% ]  ONGC 244.65  [ -0.33% ]  Punj. NationlBak 108.05  [ -1.50% ]  Power Grid Corpn. 290.95  [ 0.38% ]  Reliance Industries 1327.55  [ 0.08% ]  SBI 1038.8  [ -0.21% ]  Vedanta 282.2  [ -7.75% ]  Shipping Corpn. 321.9  [ -0.31% ]  Sun Pharmaceutical 1894.2  [ 1.65% ]  Tata Chemicals 733.15  [ -0.01% ]  Tata Consumer 1121.1  [ 0.66% ]  Tata Motors Passenge 357.5  [ -1.09% ]  Tata Steel 197.35  [ -0.80% ]  Tata Power Co. 401.05  [ -1.18% ]  Tata Consult. Serv. 2083.35  [ -2.07% ]  Tech Mahindra 1410.5  [ -1.71% ]  UltraTech Cement 11391  [ -0.09% ]  United Spirits 1346.6  [ 0.33% ]  Wipro 177.1  [ -1.67% ]  Zee Entertainment 116.01  [ 0.20% ]  
  • Share Prices
  • Tools
  • News
  • Company Details
  • Financial Data
  • Results
  • Key Financial Ratios
  • Reports
  • Corporate Announcements
  • Equity History

    • Company Information

    Indian Indices
    • Loading....

    Global Indices
    • Loading....

    Forex
    • Loading....

    AJANTA PHARMA LTD.

    23 June 2026 | 11:14

    Industry >> Pharmaceuticals

    Select Another Company

    ISIN No INE031B01049 BSE Code / NSE Code 532331 / AJANTPHARM Book Value (Rs.) 362.42 Face Value 2.00
    Bookclosure 10/11/2025 52Week High 3315 EPS 84.54 P/E 38.24
    Market Cap. 40384.08 Cr. 52Week Low 2330 P/BV / Div Yield (%) 8.92 / 0.87 Market Lot 1.00
    Security Type Other

    History of Company

    The company history sections lists out major chronological events that happened to the company.
    2005 -Max Healthcare to establish India`s first brain lab in New Delhi -Max India Ltd Max telecom ventures Ltd signed a MoU

    2008 -Max India signs agreement with UK firm for health insurance biz

    2012 -Board declares Interim Dividend of 500% i.e. Rs. 10/- for every equity share of Rs. 2/- each to the shareholders. -Ajanta Pharma Ltd has splits its face value from Rs 10/- to 5/-

    2013 - Board recommends Final Dividend 610% amounting to Rs. 12.20 per equity share of Rs. 2/- each to the shareholders. -Ajanta Pharma has announces bonus in the ratio of 1:2 2014 -Board recommends Final Dividendof 90%, i.e., Rs. 1.80 for every equity share of Rs. 2/- each to the shareholders

    2015 -Ajanta Pharma Announces the Launch of Montelukast Sodium Oral Granules -Launch of Montelukast lR Tablets and Montelukast Chewable Tablets in US market -Fortune India presents award to Ajanta Pharma -Ajanta Pharma gets approvals for 3 ANDA's -Ajanta Pharma has splits its face value from Rs. 5 to Rs. 2

    2017 -Ajanta Pharma gets USFDA nod for Duloxetine Hydrochloride. -Ajanta Pharma launches Eletriptan Hydrobromide Tablets. -Ajanta Pharma launches Clonidine Hydrochloride Extended Release Tablets in US. -Inaugurated & commissioned 1st phase at a New Facility in Guwahati, Assam, India - Dahej facility receives successful US FDA approval.

    2018 -Top Export Performer Award' by the Federation of Indian Export Organisations. -Commissioned Ajanta's 1st ever Derma facility in Guwahati.

    2019 -Ajanta Pharma USA Inc. (APUI) received DIANA award for `Best Overall Generic Manufacturer' in less than $100 mn. -New manufacturing facility for oral solid inaugurated at Pithampur.

    2020 -Ajanta's 1st Sterile Eye Drop Production Unit commissioned at Guwahati Facility.

    2021 -Listed in Fortune 500 list of Indian companies Ranked 379th in Revenue Generation (Dec 2021).

    2022

    -The Company has issued Bonus Shares in the Ratio of 1:2. -Ajanta Pharma awarded 'India's Best Managed Companies' for 2022 by Deloitte. -Ajanta wins 'Maharashtra State Best Employer Brand Awards 2022' in Pharma sector -Ajanta wins Excellence in Packaging Developed in India & Packaging Team of the Year at India Packaging Awards 2022

    2023

    The Company has infomed that, in its meeting scheduled on 10/03/2023 ,inter alia, to consider and approve the proposal for buyback of the equity shares of the Company and matters related / incidental thereto.

    -Ajanta wins 'Outstanding Export Performance Award' from Pharmexcil in 'Formulation' category

    -Ajanta wins 'Excellence in Pharma Supply Chain Management

    - Ajanta wins Times Ascent Global Best Employer Brands 2023

    2024

    -Ajanta Pharma Certified as a great place to work in India for the 2nd year.

    Way2Wealth Brokers Private Limited - CIN U67120KA2000PTC027628 Stock Broking: SEBI Regn No.: INZ000178638 | Exchange Membership ID: NSE: 11502, BSE: 3117, MSEI:51000, MCX: 56730 Depository Participant: SEBI Regn No. IN-DP-472-2020 | CDSL ID: 12062900 & 12031500, NSDL ID: IN303077 | Research Analyst: SEBI Regn No. INH200008705 | PMS: SEBI Regn No.INP000000829 | Register with AMFI ARN: 77558 (Date of Initial registration - 8th Dec 2009, Date of expiry - 24th Jan 2027) | PFRDA: POP226012019

    Way2Wealth Commodities Private Limited - CIN U51229KA2006PTC039880 Stock Broking: SEBI Regn No.: INZ000049130 | Exchange Membership ID: NCDEX : 00908

    Copyrights @ 2014 © Way2Wealth Brokers Pvt. Ltd. All rights reserved

    Designed, developed and content provided by  Dion

    Procedure to file a complaint on SEBI SCORES: Register on SCORES portal. Mandatory details for filing complaints on SCORES: Name, PAN, Address, Mobile Number, E-mail ID. Benefits: Effective Communication, Speedy redressal of the grievances.